Montanaro Asset Management Ltd decreased its holdings in Exponent, Inc. (NASDAQ:EXPO – Free Report) by 26.2% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 124,200 shares of the business services provider’s stock after selling 44,100 shares during the period. Exponent makes up about 3.0% of Montanaro Asset Management Ltd’s portfolio, making the stock its 16th biggest position. Montanaro Asset Management Ltd owned about 0.24% of Exponent worth $10,068,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently modified their holdings of EXPO. Whipplewood Advisors LLC increased its stake in shares of Exponent by 5,333.3% in the 1st quarter. Whipplewood Advisors LLC now owns 326 shares of the business services provider’s stock valued at $26,000 after purchasing an additional 320 shares during the last quarter. UMB Bank n.a. increased its stake in shares of Exponent by 859.1% in the 1st quarter. UMB Bank n.a. now owns 633 shares of the business services provider’s stock valued at $51,000 after purchasing an additional 567 shares during the last quarter. Bessemer Group Inc. increased its stake in shares of Exponent by 103.3% in the 1st quarter. Bessemer Group Inc. now owns 681 shares of the business services provider’s stock valued at $55,000 after purchasing an additional 346 shares during the last quarter. Johnson Financial Group Inc. bought a new position in shares of Exponent in the 4th quarter valued at $59,000. Finally, LRI Investments LLC increased its stake in shares of Exponent by 30.4% in the 4th quarter. LRI Investments LLC now owns 1,460 shares of the business services provider’s stock valued at $130,000 after purchasing an additional 340 shares during the last quarter. Institutional investors own 92.37% of the company’s stock.
Insider Buying and Selling
In related news, VP John Pye sold 2,000 shares of the business’s stock in a transaction on Friday, May 23rd. The stock was sold at an average price of $76.32, for a total transaction of $152,640.00. Following the sale, the vice president owned 29,204 shares in the company, valued at $2,228,849.28. The trade was a 6.41% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, VP Joseph Rakow sold 1,573 shares of the business’s stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $77.72, for a total value of $122,253.56. The disclosure for this sale can be found here. Insiders have sold 6,267 shares of company stock worth $489,120 in the last 90 days. Insiders own 1.60% of the company’s stock.
Exponent Stock Performance
Exponent (NASDAQ:EXPO – Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The business services provider reported $0.52 earnings per share for the quarter, topping analysts’ consensus estimates of $0.48 by $0.04. The business had revenue of $132.87 million for the quarter, compared to analyst estimates of $130.82 million. Exponent had a return on equity of 24.19% and a net margin of 18.35%. Exponent’s quarterly revenue was up 7.3% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.57 EPS. As a group, research analysts forecast that Exponent, Inc. will post 1.98 EPS for the current fiscal year.
Exponent Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 19th. Investors of record on Friday, September 5th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, September 5th. This represents a $1.20 dividend on an annualized basis and a yield of 1.7%. Exponent’s payout ratio is currently 60.00%.
About Exponent
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Featured Articles
- Five stocks we like better than Exponent
- Which Wall Street Analysts are the Most Accurate?
- CrowdStrike Faces Valuation Test Before Key Earnings Report
- How Can Investors Benefit From After-Hours Trading
- MNDY Stock Has a Case of the Mondays—Buy Before the Rebound
- What is a support level?
- IPO Market Stays Hot With These 2 Debuting Stocks
Receive News & Ratings for Exponent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exponent and related companies with MarketBeat.com's FREE daily email newsletter.